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Abstract
Background: Multimorbidity is recognized internationally as having a serious impact on health outcomes. It is associated with reduced quality 
of life, increased health care utilization, and future functional decline. Physical activity is associated with good health and psychological 
well-being. The aim of this study was to identify the impact of physical activity and physical function on the development and worsening of 
multimorbidity over time.
Methods: Using The Irish Longitudinal Study on Ageing (TILDA), we analyzed 4,823 participants ≥50 years with and without multimorbidity. 
Multimorbidity was defined as the presence of ≥2 chronic conditions. Development of multimorbidity was measured as the accrual of additional 
conditions over a 2-year period. Physical activity and physical function were measured using the International Physical Activity Questionnaire 
(IPAQ), gait speed (m/sec), and grip strength (kg).
Results: Sixteen groups of chronic conditions were included in analyses. 53.7% of included participants had multimorbidity at baseline and 
71.7% at follow-up. Six hundred and thirty-eight of 2,092 (30.4%) participants without multimorbidity and 1,005 of 2,415 (41.6%) with 
existing multimorbidity developed new condition/s. Gait speed (relative risk [RR] = 0.67, confidence interval [CI]: 0.49–0.90), grip strength 
(RR = 0.98, CI: 0.97–0.99), and age (compared to 50–59 years, 60–69: RR = 1.30, CI: 1.11–1.52; ≥70: RR = 1.35, CI: 1.03–1.77) were 
significantly associated with the development of multimorbidity and accrual of additional conditions.
Conclusion: These results show that physical function is associated with the development and worsening of multimorbidity over time. They 
support the recent National Institute for Health & Care Excellence (NICE) Guidance on multimorbidity that suggests that patients with 
multimorbidity and reduced gait speed should be identified and targeted for interventions to improve health outcomes.
Keywords: Multiple chronic conditions, Gait speed, Grip strength, Longitudinal study
Background
Average life expectancy is rising worldwide with increasing numbers of 
people living with multiple chronic medical conditions. Multimorbidity, 
commonly defined as the co-occurrence of two or more chronic 
medical conditions in an individual (1), affects up to one quarter of 
primary care populations (2,3). Higher prevalence is associated with 
socioeconomic deprivation and ageing (2). It is associated with reduced 
quality of life, increased health care utilization, and an increased risk of 
mental health difficulties (1,2,4). Complex multimorbidity, defined as 
three or more chronic conditions affecting three or more body systems 
can be especially challenging with higher health care utilization and 
polypharmacy (5). Management of multimorbidity is a major chal-
lenge for health systems globally. It has been reported that one third 
of all consultations in general practice in the United Kingdom are for 
patients with more than one chronic condition (6).
The World Health Organization estimates that approximately 
3.2 million deaths each year are attributable to insufficient phys-
ical inactivity (7). Older adults who are more physically active have 
lower rates of cardiovascular disease, cancer, and all-cause mor-
tality along with improved cognition and reduced risk of falling (7). 
Physical activity prevents or reduces functional decline (8,9). The 
existing literature examining the association between multimorbid-
ity and physical activity has demonstrated mixed results with two 
studies findings an association (10,11) and two reporting no link 
(12,13). However, these studies were all cross-sectional in design 
and did not assess the trends in multimorbidity over time. One pre-
vious longitudinal study investigated the prevalence of multimorbid-
ity over time by levels of physical activity and identified an inverse 
dose–response relationship in that the odds of multimorbidity were 
lower in those who were physically active compared to those who 
were physically inactive (14). This study included refreshment sam-
ples at different time-points which may have affected estimates and 
the only outcome measure used was a study specific self-reported 
measure of physical activity.
Poor physical functioning is also linked to adverse health 
outcomes (15) and is addressed by the WHO’s International 
Classification of Functioning, Disability and Health (ICF) (16). Grip 
strength and gait speed assessments are reliable measures of physical 
function (17). Grip strength has been reported to predict accelerated 
dependency in activities of daily living and cognitive decline in older 
people (18). Gait speed has been described as the sixth vital sign and 
labeled as a principal indicator of health and is an inexpensive, reli-
able measure of physical function (19).
We previously conducted a systematic review which demon-
strated that multimorbidity is associated with poorer function and 
with future functional decline. The review indicated that there is 
greater functional decline in patients with higher numbers of condi-
tions and greater disease severity (20). It is not known whether the 
effect also occurs in the opposite direction, that is, do poor levels 
of physical activity and function lead to the development of multi-
morbidity? Determining the impact of levels of physical activity and 
physical function on multimorbidity development will inform health 
care providers and aid the design of appropriate interventions that 
can improve health outcomes and reduce health care costs.
The primary aim of this study was to assess the impact of phys-
ical activity and function on the development of multimorbidity over 
a 2-year period in an older population without multimorbidity at 
baseline. Secondary aims were to assess the impact of physical ac-
tivity and function on the worsening of multimorbidity over a 2-year 
period in a population of older adults with established multimorbid-
ity and in those with complex multimorbidity at baseline.
Methods
Study Design
We completed secondary analysis of a longitudinal cohort study. The 
strengthening the reporting of observational studies in epidemiology 
(STROBE) guidelines were utilized in the conduct and reporting of 
this study (21).
Data Source and Study Population
The Irish Longitudinal Study on Ageing (TILDA) is a population-
based cohort study assessing health, economic, and social aspects of 
ageing in the Republic of Ireland. TILDA is a nationally represen-
tative study of 8,175 community-dwelling residents aged 50 years 
and older (22). This study is an analysis of the first (2010) and 
second (2012) waves of TILDA. At Wave 1 participants completed a 
computer-assisted personal interview in their own home and subse-
quently were invited to attend a health centre for a comprehensive 
health assessment. Ethical approval for TILDA was obtained from 
the Trinity College Dublin Research Ethics Committee.
Included Conditions
Thirty individual chronic conditions were included in analyses. The 
30 chronic conditions were chosen by TILDA as of their public 
health significance and their prevalence in those more than 50 years 
(23). These conditions were consolidated to 16 chronic conditions 
or groups of conditions: cardiac conditions; cerebrovascular disease; 
hypertension; diabetes; high cholesterol; chronic respiratory disease; 
liver disease; eye disease; cognitive impairment; arthritis; osteopor-
osis; cancer; Parkinson’s disease; emotional /psychological condi-
tion; stomach ulcers; varicose veins (Supplementary Appendix A).
Multimorbidity was defined as two or more chronic conditions 
in the one individual. The study participants were grouped into two 
categories: no multimorbidity (zero or one condition) n  =  2,235 
and established multimorbidity (two or more conditions) n = 2,588 
at Wave 1.  These groups of participants were followed to Wave 
2. Development of multimorbidity and worsening of multimorbidity 
was measured by accrual of new condition/s between Wave 1 and 
Wave 2. In addition, we completed a subgroup analysis, following 
participants with complex multimorbidity (≥3 chronic conditions) 
n = 2,415 at baseline to Wave 2.
Measures of Physical Activity and Function
Levels of physical activity and function were assessed using three 
validated outcome measures: the International Physical Activity 
Questionnaire (IPAQ), gait speed, and grip strength (22,24). The 
IPAQ is a self-reported measure and gait speed and grip strength are 
performance-based assessments. Only study participants with com-
plete data recorded on all three measures were included (Figure 1).
Physical activity was measured using the short form of the IPAQ 
(25). Each participant was classified as having High, Moderate or 
Low activity levels based on agreed criteria (26).
Grip strength was measured using a grip dynamometer, two 
measures of handgrip strength were taken from the dominant hand 
and the mean of these readings was calculated. Gait speed was meas-
ured using the GAITRite portable electronic walkway system (24). 
Participants performed two walks at their usual pace along a 4.88 
m (16ft) walkway. They started and finished walking 2.5 m before 
and 2 m after the walkway to allow for acceleration and deceler-
ation. The two walks were combined and the average gait speed was 
calculated.
Statistical Analysis
A modified Poisson regression analysis with robust error variances 
was used to determine the relationship between levels of physical 
activity and function with both the development of multimorbidity 
and worsening of multimorbidity. Binary outcomes in cohort studies 
are commonly analyzed using a logistic regression model to obtain 
odds ratios. However, in order to estimate and report relative risks 
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and confidence intervals, we used a modified Poisson regression ana-
lysis with robust error variances.
Confounders and Covariates
Age and sex were included in the models as covariates. To make 
analysis comparable to other similar studies age was categorized 
in 10-year age bands; 50–59 years; 60–69 years; ≥70 years (2,13). 
Additional confounders included in the analysis were education 
level, body mass index (BMI), and smoking (smoker, nonsmoker). 
Participants deemed as underweight (0.5%), were merged with 
the normal category for BMI. The presence of state financial sup-
port for health care was used as a proxy for socioeconomic status. 
Measurement for each of the variables has been described previously 
(22,24,26).
Results are presented as adjusted relative risks (RR) with associ-
ated 95% confidence intervals (CI). p Values ≤.05 were deemed sig-
nificant. All analyses were conducted using Stata Version 13.0 (Stata 
Statistical Software: Release 13. College Station, TX: StataCorpLP).
Results
Characteristics of the Sample
Included participants (n  =  4,823) are presented in Figure  1. The 
characteristics of the study population are displayed in Table 1. At 
Wave 1, 2,235 (46.3%) participants did not have multimorbidity 
and 2,588 (53.7%) had multimorbidity. The two groups were signifi-
cantly different in all categories at baseline (Table 1). We completed 
a test of gender interaction and there was no significant difference 
between male and females and thus no evidence to warrant stratify-
ing the data by gender. Those with multimorbidity were older than 
those without multimorbidity and the majority in both groups were 
nonsmokers and overweight or obese. The most common conditions 
in study participants were high cholesterol (41.3%), high blood pres-
sure (33.6%) and arthritis (26.3%), while the prevalence of other 
conditions such as cardiac conditions, diabetes, respiratory disease, 
eye disease, and osteoporosis varied from 6.1% to 16.7%. These 
results are in keeping with previous research which demonstrated 
high blood pressure, arthritis, and cardiovascular disease to be the 
most prevalent conditions in a cohort aged 65 years or older (27).
Development of Multimorbidity
Of the 2,235 participants with no multimorbidity at baseline, 2,092 
(93.6%) were followed up 2 years later. By Wave 2, 638 (30.4%) 
had developed multimorbidity. Multivariate analysis demonstrated 
that age (compared to 50–59 years, 60–69 years: RR = 1.30, 95% 
CI: 1.11–1.52; ≥70 years: RR = 1.35, 95% CI: 1.03–1.77), obesity 
(compared to normal and underweight: RR = 1.26, 95% CI: 1.05–
1.51), gait speed (RR = 0.67, 95% CI: 0.49–0.90), and grip strength 
(RR = 0.98, 95% CI: 0.97–0.99) were significantly associated with 
the development of multimorbidity. There was no evidence of an 
association between IPAQ and the development of multimorbidity 
(Table 2). With every one kilogram increase in grip strength, the risk 
of developing multimorbidity decreases. Similarly, each meter per 
second increase in gait speed decreases the risk of developing multi-
morbidity (Table 2).
Worsening of Multimorbidity
Of the 2,588 participants with multimorbidity at baseline, 2,415 
(93.3%) were followed up 2 years later. Of these, 1,005 (41.6%) had 
developed worsened multimorbidity in Wave 2. Age (compared to 
50–59 years, 60–69 years: RR = 1.20, 95% CI: 1.07–1.34; ≥70 years: 
RR = 1.18, 95% CI: 1.01–1.37), access to government funded pri-
mary health care (RR  =  1.20, 95% CI: 1.07–1.34), grip strength 
(RR = 0.990, 95% CI: 0.982–0.998), and gait speed (RR = 0.61, 
95% CI: 0.50–0.82), were all significantly associated with worsening 
of multimorbidity. For every one kilogram increase in grip strength 
the incidence of worsening multimorbidity decreases. For each meter 
per second increase in gait speed, the risk of worsening multimorbid-
ity also decreases. There was no significant association between the 
IPAQ and the worsening of multimorbidity (Table 2).
Complex Multimorbidity
1,488 participants presented with complex multimorbidity at 
baseline (Supplementary Appendix B), 1,391 of these participants 
were followed up in Wave 2.  Six hundred of the 1,391 partici-
pants (43.1%) with complex multimorbidity had developed a new 
condition/s. Gait speed (RR = 0.59; 95% CI: 0.43–0.82), and age 
(compared to 50–59 years, 60–69 years: RR = 1.18, 95% CI: 1.02–
1.36; ≥70 years: RR = 1.20, 95% CI: 1.10–1.44), were significantly 
associated with the development of new conditions but grip strength 
was not (Supplementary Appendix C).
Discussion
This study presents a longitudinal analysis of multimorbidity in a 
nationally-representative, population-based sample of older adults. 
Over a 2-year follow-up period, 30.4% developed multimorbidity 
and 41.6% with multimorbidity experienced worsening multimor-
bidity. Gait speed, grip strength, and increasing age were significantly 
associated both with the development of multimorbidity and the 
worsening of existing multimorbidity with evidence of a dose–re-
sponse relationship.
Figure 1. Study participants flow chart.
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Grip strength is a predictor of cognitive decline, disability and 
contributes to increasing dependency in old age (18). Our study high-
lighted that the stronger one’s grip strength the less likely new chronic 
conditions will develop within 2 years. Gait speed assessment is also a 
valuable tool in the clinical assessment of frailty and lower gait speed 
is associated with reduced strength, power, coordination, and bal-
ance (19,28). Our results support the recent NICE Multimorbidity 
Guidance, which recommends using gait speed as an assessment meas-
ure to identify those patients who require prioritized/targeted care 
(29). NICE is the National Institute for Health Care and Excellence 
based in the United Kingdom. They provide evidence-based national 
guidance to all stakeholders with the aim to improve health and social 
care. While our study highlighted the clinical relevance of reduced gait 
speed, we did not identify a specific cut-point at which the risk of mul-
timorbidity increased. Further research in this area is needed.
Dhalwanai et al. demonstrated an inverse dose–response associ-
ation between levels of physical activity and multimorbidity using fre-
quency of vigorous, moderate, and mild physical activity (14). They 
highlighted the potential that the existence of multimorbidity may 
limit physical activity, which could also have happened in our cohort. 
The Dhalwhani study had a similar definition of multimorbidity but 
only included 16 chronic conditions compared to 30 in our study. In 
addition, the only outcome measure used was a study-specific self-
report measure which was shown to have moderate correlation with 
accelerometer data. In our study, there was no evidence that the self-
reported outcome measure, the IPAQ, was associated with develop-
ment or worsening of multimorbidity. It has been acknowledged in 
the literature that over-reporting amounts of physical activity when 
completing the IPAQ is common, with older adults having difficulty 
completing it accurately (30). The IPAQ is recommended for popu-
lation level research, however is not intended to replace instruments 
which can be more responsive to changes in individual activity level 
such as gait speed. Comparisons with the previous cross-sectional 
studies (10–13) is difficult due to different measures of physical activ-
ity, differences in study population, and definitions of multimorbidity 
used. Accelerometer measurements would provide added value, how-
ever, gait speed and grip strength assessments are cost-effective and 
easily accessible measurements used in clinical practice.
In keeping with the evidence that obesity has negative impacts 
on health outcomes, individuals in our study with obesity were 
Table 1. Baseline characteristics of study participants
No multimorbidity
0/1 condition
n= 2235 (46.3%)
Multimorbidity
2/more conditions
n= 2588 (53.7%) p Value
Age
 50–59 1282 (57.4%) 893 (34.5%) <0.001
(c) 60–69 697 (31.2%) 995 (35.4%)
 70+ 252 (11.3%) 696 (26.9%)
Sex
 Male 1115 (49.9%) 1106 (42.7%) <0.001
(c) Female 1120 (50.1%) 1482 (57.3%)
Education
 Primary/ none
 Secondary
 Third/ higher
401 (17.9%)
1003 (44.9%)
830 (37.1%)
653 (25.2%)
1008 (38.9%)
926 (35.8%)
<0.001
(c)
Body Mass Index (kg/m2)
 Underweight (< 18.5) 12 (0.5%) 9 (0.3%) <0.001
(c) Normal (18.5 -25) 566 (25.3%) 518 (20.0%)
 Overweight (25.1 -30) 1021 (45.7%) 1097 (42.4%)
 Obese (≥30.1) 634 (28.4%) 963 (37.2%)
Smoking Status
 Non-smoker 1865 (83.5%) 2244 (86.7%) 0.001
(c) Smoker 370 (16.5%) 344 (13.3%)
State support
 No medical/ General Practitioner card 1628 (78.8%) 1338 (51.7%) <0.001
(c) Medical/ General Practitioner card 605 (27.1%) 1249 (48.3%)
International Physical Activity
 Questionnaire (IPAQ)
 Low exercise 539 (24.1%) 782 (30.2%) <0.001
(c) Moderate exercise 761 (34.1%) 994 (38.4%)
 High exercise 935 (41.8%) 812 (31.4%)
Grip Strength (kg) Mean (SD) Mean (SD)
 50–59 28.5 (9.9) 26.8 (9.8) <0.001
(t) 60–69 27.0 (8.9) 24.8 (8.8)
 70+ 24.6 (8.6) 21.9 (8.3)
 Total 27.6 (9.5) 24.7 (9.2)
Gait Speed (m/second) Mean (SD) Mean (SD)
 50–59 1.4 (0.2) 1.4 (0.2) <0.001
(t) 60–69 1.4 (0.2) 1.3 (0.2)
 70+ 1.3 (0.2) 1.2 (0.2)
 Total 1.4 (0.2) 1.3 (0.2)
Note: Confounder variables missing <0.2% data in all cases; c= chi-squared test; t= t-test.
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more likely to develop multimorbidity compared to those of nor-
mal weight though obesity was not associated with worsening of 
multimorbidity over time. The results regarding socioeconomic sta-
tus were mixed. This may relate to the higher prevalence of socio-
economic deprivation in those with established multimorbidity at 
baseline. These results may also relate to the measure used as it does 
not identify the most socioeconomically deprived groups within the 
cohort as income thresholds for access to government funded health 
care increases with age. Existing evidence highlights that, patients 
with higher levels of socioeconomic deprivation develop multimor-
bidity significantly earlier in life than their more affluent counter-
parts (2). Dhalwanai et al. included socioeconomic status and BMI 
as confounders but did not comment whether either impacted on the 
presence of multimorbidity over time (14).
Strengths and Limitations
TILDA is a nationally representative population based cohort 
study using validated measures and health assessments carried out 
by trained research nurses using standardized protocols (24). We 
included 30 different conditions in our analysis encompassing a 
broad range of conditions including mental health conditions which 
are commonly omitted in other studies.
A potential limitation of this study may relate to participant 
characteristics. The outcome measures used to measure physical 
activity and function dictated that TILDA participants who did 
not attend the health centre assessment were excluded. It has been 
demonstrated that those who were frail or disabled or more elderly 
were less inclined to attend the health centre for assessment and thus 
presents a potential source of bias (22). As with other longitudinal 
studies of ageing, all participants were required to provide written 
informed consent to participate in the study at Wave 1; this will have 
resulted in the exclusion of individuals with severe cognitive impair-
ment. We also need to acknowledge those who were lost to follow 
up, though this was minimal with 6.6% (n = 148) participants with 
no multimorbidity and 7.2% (n = 173) participants with multimor-
bidity not available for analysis 2 years later. A further limitation is 
that the definition of multimorbidity used does not take into account 
disease severity. However, we did use the most commonly reported 
definition, that is, ≥2 chronic conditions and we also conducted 
analyses examining complex multimorbidity (≥3 chronic condi-
tions) with complex multimorbid patients having higher care needs 
(5). The use of self-reported diagnoses in the analysis may be an 
additional limitation. However, evidence has demonstrated moder-
ate to good agreement between self-reported and physician-reported 
chronic conditions among multimorbid patients (31). A final limita-
tion was the use of State financial support as a proxy for socioeco-
nomic status. While state financial support is an accurate proxy for 
socioeconomic status in Irish people under the age of 70, over this 
Table 2. Multivariable Poisson Regression Model for Development of Multimorbidity in Those With no Multimorbidity at Baseline and 
Worsening Multimorbidity in Those With Multimorbidity at Baseline, Over a 2-y Period in Adults Aged 50 y and Over (TILDA Waves 1 and 2)
No multimorbidity
Relative risks and 95% confidence 
intervals of those with no multi-
morbidity at baseline p Value
Multimorbidity
Relative risks and 95% confidence 
intervals of those with multimor-
bidity at baseline p Value
Age
50–59 1.00 1.00
60–69 1.30 (1.11–1.52) .001 1.20 (1.07–1.34) .002
70+ 1.35 (1.03–1.77) .027 1.18 (1.01–1.37) .039
Sex
Male 1.00 1.00
Female 1.05 (0.86–1.27) .649 0.95(0.83–1.09) .468
Education
Secondary 1.00 1.00
Primary/none 1.10 (0.93–1.30) .279 0.94 (0.84–1.06) .314
Third/higher 0.96 (0.83–1.11) .582 1.02 (0.91–1.14) .760
Body Mass Index
Normal: 18.5–25 1.00 1.00
and underweight:<18.5 1.09 (0.92–1.28) .319 0.96 (0.85–1.09) .542
Overweight:25.1–30 1.26 (1.05–1.51) .011 0.96 (0.84–1.10) .572
Obese: ≥30.1
Smoking
Nonsmoker 1.00 1.00
Smoker 1.08 (0.91–1.29) .361 1.06 (0.92–1.22) .457
State Support
No medical/General Practitioner 
card
Medical/ General 
1.00 1.00
Practitioner card 1.13 (0.97–1.31) .130 1.20 (1.07–1.34) .002
International Physical 
Activity Questionnaire (IPAQ)
Low exercise
1.00 1.00 .309
Moderate 1.00 (0.85–1.19) .969 0.94 (0.85–1.06) .168
High exercise 1.04 (0.88–1.23) .640 0.92 (0.81–1.04)
Grip Strength (kg) 0.98 (0.97–0.99) .002 0.990 (0.982–0.998) .014
Gait Speed (m/s) 0.67 (0.49–0.90) .046 0.61 (0.50–0.82) <.001
The bold values indicate results demonstrating statistical significance.
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age different income thresholds apply and there is nearly universal 
coverage for this age group. However, the majority of our cohort 
(80.3%) were less than 70 years.
Conclusion
With an ageing population, the management of chronic medical con-
ditions is at the forefront of health care planning and policy. Our 
results have implications for clinical practice in that assessment 
of physical function and appropriate intervention may prevent an 
inevitable cascade toward poorer health outcomes. Future research 
should focus on the development of interventions which priori-
tize physical function for this patient group to prevent the poorer 
health outcomes and increased health care costs associated with 
multimorbidity.
Key points
• Gait speed, grip strength, and increasing age were shown to 
be significantly associated with the development of multimor-
bidity and the worsening of existing multimorbidity.
• Faster gait speed and stronger grip strength were found to be 
associated with a reduced risk of developing new conditions.
• Poor levels of physical function, as measured by grip strength and 
gait speed lead to the worsening of multimorbidity over time.
• These results support the NICE Multimorbidity Guidance (2016), 
which recommends using gait speed as an assessment measure to 
identify those patients who require prioritized/targeted care.
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